Lin Gao Selected Research

Dye Lasers

1/2020	A retrospective analysis for facial telangiectasia treatment using pulsed dye laser and intense pulsed light configured with different wavelength bands.
1/2018	Topical Halometasone Reduces Acute Adverse Effects Induced by Pulsed Dye Laser for Treatment of Port Wine Stain Birthmarks.
11/2017	A Retrospective Study on Efficacy of Pulsed Dye Laser and Intense Pulsed Light for the Treatment of Facial Telangiectasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lin Gao Research Topics

Disease

34	Neoplasms (Cancer) 08/2022 - 01/2004
19	Hypoxia (Hypoxemia) 01/2022 - 07/2004
15	Inflammation (Inflammations) 01/2022 - 03/2007
11	Prostatic Neoplasms (Prostate Cancer) 04/2022 - 06/2008
11	Pancreatitis 01/2022 - 01/2016
8	Parkinson Disease (Parkinson's Disease) 11/2021 - 11/2008
8	Fibrosis (Cirrhosis) 10/2021 - 03/2007
7	Insulin Resistance 09/2022 - 01/2016
7	Atherosclerosis 12/2019 - 08/2015
6	Infections 05/2022 - 10/2014
6	Reperfusion Injury 01/2022 - 01/2014
6	Hepatocellular Carcinoma (Hepatoma) 12/2019 - 06/2007
6	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2017 - 09/2008
5	Breast Neoplasms (Breast Cancer) 10/2022 - 01/2018
5	Myocardial Infarction 01/2022 - 10/2008
5	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2007
5	Ischemia 12/2021 - 06/2008
5	Type 2 Diabetes Mellitus (MODY) 05/2020 - 03/2015
5	Obesity 03/2018 - 06/2013
5	Vascular System Injuries 01/2017 - 08/2010
4	Acute Necrotizing Pancreatitis 12/2021 - 12/2020
4	Infarction (Infarctions) 10/2019 - 10/2008
4	Vitiligo 06/2019 - 03/2009
3	Fistula 02/2022 - 12/2020
3	Hemorrhage 02/2022 - 12/2017
3	Carcinogenesis 01/2022 - 01/2018
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 01/2014
3	Colorectal Neoplasms (Colorectal Cancer) 07/2021 - 01/2018
3	Atherosclerotic Plaque (Atheroma) 12/2019 - 10/2016
3	Carcinoma (Carcinomatosis) 04/2019 - 01/2015
3	Port-Wine Stain (Nevus Flammeus) 01/2018 - 11/2014
3	Lung Injury 01/2018 - 01/2016
3	Hypertension (High Blood Pressure) 01/2017 - 08/2002
2	Lung Neoplasms (Lung Cancer) 10/2022 - 09/2021
2	Colonic Neoplasms (Colon Cancer) 10/2022 - 06/2016
2	Triple Negative Breast Neoplasms 09/2022 - 01/2021
2	Body Weight (Weight, Body) 09/2022 - 01/2016
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 09/2022 - 05/2020
2	Papillary Thyroid Cancer 08/2022 - 12/2017
2	Erythema 08/2022 - 01/2018
2	Acne Vulgaris 08/2022 - 03/2022
2	Hyperglycemia 01/2022 - 05/2003
2	Pain (Aches) 01/2022 - 01/2018
2	Shock 01/2022 - 01/2021
2	COVID-19 01/2022 - 11/2021
2	Sepsis (Septicemia) 12/2021 - 01/2021
2	Parkinsonian Disorders (Parkinsonism) 11/2021 - 04/2006
2	Adenocarcinoma of Lung 09/2021 - 04/2019
2	Gliosis 08/2021 - 01/2019

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 04/2022 - 03/2007
10	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 11/2015
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2013
9	Messenger RNA (mRNA)IBA 09/2021 - 08/2002
7	MicroRNAs (MicroRNA)IBA 10/2022 - 09/2013
6	CeruletideIBA 01/2021 - 01/2016
6	Ion Channels (Ion Channel)IBA 01/2020 - 02/2012
6	Tissue Kallikreins (Tissue Kallikrein)IBA 01/2013 - 06/2008
5	Glucose (Dextrose)FDA LinkGeneric 09/2022 - 01/2014
5	AndrogensIBA 04/2022 - 01/2019
5	CytokinesIBA 01/2022 - 06/2013
5	InflammasomesIBA 01/2022 - 01/2017
5	Long Noncoding RNAIBA 01/2021 - 04/2018
5	Biological ProductsIBA 01/2021 - 08/2010
5	CollagenIBA 01/2021 - 08/2010
5	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 04/2019 - 05/2017
5	kallistatinIBA 01/2017 - 11/2008
5	KininsIBA 07/2010 - 03/2007
4	enzalutamideIBA 04/2022 - 01/2020
4	EnzymesIBA 01/2022 - 07/2004
4	Pharmaceutical PreparationsIBA 11/2021 - 01/2019
4	NF-kappa B (NF-kB)IBA 01/2021 - 09/2008
4	NAD (NADH)IBA 01/2020 - 01/2017
4	Kallikreins (Kallikrein)IBA 04/2010 - 06/2008
3	KinesinsIBA 09/2022 - 01/2021
3	naringeninIBA 09/2022 - 01/2018
3	Peptides (Polypeptides)IBA 04/2022 - 06/2008
3	Oxygen (Dioxygen)IBA 01/2022 - 04/2016
3	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 01/2020
3	Arginine (L-Arginine)FDA Link 01/2021 - 10/2014
3	Taurine FDA Link 12/2020 - 10/2002
3	Caspase 3 (Caspase-3)IBA 12/2020 - 10/2008
3	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 05/2020 - 01/2018
3	Cadherins (E-Cadherin)IBA 04/2019 - 04/2009
3	Triglycerides (Triacylglycerol)IBA 01/2019 - 01/2017
3	LipopolysaccharidesIBA 01/2019 - 01/2017
3	Blood Glucose (Blood Sugar)IBA 01/2018 - 10/2016
3	Amylases FDA Link 01/2018 - 01/2016
3	Lipase (Acid Lipase)FDA Link 01/2018 - 01/2016
3	Apolipoproteins E (ApoE)IBA 10/2016 - 08/2015
2	Hormones (Hormone)IBA 09/2022 - 10/2021
2	SolutionsIBA 01/2022 - 06/2019
2	Proteasome Endopeptidase Complex (Proteasome)IBA 09/2021 - 01/2012
2	RNA (Ribonucleic Acid)IBA 07/2021 - 01/2021

Therapy/Procedure

15	Therapeutics 08/2022 - 07/2012
6	Drug Therapy (Chemotherapy) 01/2021 - 01/2015
3	Castration 04/2022 - 01/2019
3	Length of Stay 02/2022 - 12/2021
3	Dye Lasers 01/2020 - 11/2017
2	Lasers (Laser) 03/2022 - 06/2019
2	Sympathectomy (Sympathectomies) 01/2022 - 12/2016